Pulmonary cytolytic thrombi: Unusual complication of hematopoietic stem cell transplantation

Ian J. Morales, Peter M. Anderson, Henry D. Tazelaar, Mark E. Wylam

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

Pulmonary complications of hematopoietic stem cell transplantation (HSCT), including peripheral blood stem cell transplantation (PBSCT) and bone marrow transplantation, are frequent and often life-threatening. Differentiating acute infectious from noninfectious pulmonary complications is difficult but critical for proper treatment. The authors describe an 11-year-old boy who developed a sudden fever and cough associated with a normal chest radiograph 2 months after successful haploidentical PBSCT for severe aplastic anemia. High-resolution chest computed tomography revealed numerous tiny peripheral pulmonary nodules. Lung biopsy demonstrated an unusual occlusive thrombotic vascular lesion associated with hemorrhagic infarction without evidence of infection. The thrombi were composed of intensely basophilic granular material recently described as "cytolytic" thrombi. Symptoms and chest computed tomography improved rapidly following intravenous corticosteroids and cyclosporin. However, the patient subsequently died of rapidly progressive pulmonary hypertension. Our patient illustrates the importance of considering this noninfectious complication in the acute pulmonary disorders associated with HSCT as this condition may represent a pulmonary manifestation of acute graft-versus-host disease.

Original languageEnglish (US)
Pages (from-to)89-92
Number of pages4
JournalJournal of Pediatric Hematology/Oncology
Volume25
Issue number1
DOIs
StatePublished - Jan 2003

Keywords

  • Bone marrow transplantation/adverse effects
  • Graft-versus-host disease
  • Pulmonary embolism/pathology

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Pulmonary cytolytic thrombi: Unusual complication of hematopoietic stem cell transplantation'. Together they form a unique fingerprint.

Cite this